Zimmer Biomet receives FDA clearance of baseplate for shoulder reconstruction
Zimmer Biomet Holdings Inc. announced it received FDA clearance for its Comprehensive Augmented Baseplate, which offers an alternative to bone grafting and eccentric reaming for patients with glenoid defects undergoing shoulder reconstruction.
A component of the Comprehensive Reverse Shoulder System, according to a company press release, the Comprehensive Augmented Baseplate allows for augment placement in any orientation to accommodate various unique bone anatomies with its simplified circular design at 3mm, 5mm and 7mm buildup. The release also the circular design allows bone ingrowth into the rim of the baseplate for optimal fixation.
“The new Augmented Baseplate rounds out Zimmer Biomet’s Comprehensive Shoulder portfolio and provides solutions that help surgeons with difficult glenoid deformity cases,” Orsa Britton, vice president and general manager of Zimmer Biomet’s global extremities business, said in the release.
Reference: